Research ArticleNuclear Oncology
Fluorine-18-FDG PET Imaging Is Negative in Bronchioloalveolar Lung Carcinoma
Kotaro Higashi, Yoshimichi Ueda, Hiroyasu Seki, Kokichi Yuasa, Manabu Oguchi, Tetsuhiko Noguchi, Mitsuru Taniguchi, Hisao Tonami, Tetsuro Okimura and Itaru Yamamoto
Journal of Nuclear Medicine June 1998, 39 (6) 1016-1020;
Kotaro Higashi
Yoshimichi Ueda
Hiroyasu Seki
Kokichi Yuasa
Manabu Oguchi
Tetsuhiko Noguchi
Mitsuru Taniguchi
Hisao Tonami
Tetsuro Okimura
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Fluorine-18-FDG PET Imaging Is Negative in Bronchioloalveolar Lung Carcinoma
Kotaro Higashi, Yoshimichi Ueda, Hiroyasu Seki, Kokichi Yuasa, Manabu Oguchi, Tetsuhiko Noguchi, Mitsuru Taniguchi, Hisao Tonami, Tetsuro Okimura, Itaru Yamamoto
Journal of Nuclear Medicine Jun 1998, 39 (6) 1016-1020;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
- Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer
- Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
- Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data
- Evaluation of the Biodistribution of 11C-Methionine in Children and Young Adults
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
- Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT
- 18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non-Small Cell Lung Cancer
- Screening for Cancer with PET and PET/CT: Potential and Limitations
- Integrating PET and CT Information to Improve Diagnostic Accuracy for Lung Nodules: A Semiautomatic Computer-Aided Method
- Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with 18F-FDG Uptake Below the Standardized Uptake Value of 2.5
- Microvessel Density: Correlation with 18F-FDG Uptake and Prognostic Impact in Lung Adenocarcinomas
- PET Evaluation of Lung Cancer
- 18F-FDG Imaging: Pitfalls and Artifacts
- 18F-FDG Uptake by Primary Tumor as a Predictor of Intratumoral Lymphatic Vessel Invasion and Lymph Node Involvement in Non-Small Cell Lung Cancer: Analysis of a Multicenter Study
- Diagnostic Value and Limitations of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Cartilaginous Tumors of Bone
- Current Concepts in Lymph Node Imaging
- Quantification of 18F-FDG Uptake in Non-Small Cell Lung Cancer: A Feasible Prognostic Marker?
- Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules
- Imaging in lung cancer: positron emission tomography scan
- 18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected Non-Small Cell Lung Cancer
- Comparison of [18F]FDG PET and 201Tl SPECT in Evaluation of Pulmonary Nodules
- Whole body applications of positron emission tomography in oncology
- The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
- Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non-Small-Cell Lung Cancer: A Prospective Study
- Assessment of Malignancy in Pulmonary Lesions: FDG Dual-Head Coincidence Gamma Camera Imaging in Association with Serum Tumor Marker Measurement
- Lung Cancer Proliferation Correlates with [F-18]Fluorodeoxyglucose Uptake by Positron Emission Tomography